Etravirine (ETR)
Paul A. Pham, Pharm.D. BCPS, Alice Jenh Hsu, Pharm.D
Etravirine (ETR) is a topic covered in the
Johns Hopkins HIV Guide.
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

-- The first section of this topic is shown below --
INDICATIONS
- In combination with other ARV agents for the treatment of HIV-1 infection in treatment-experienced pts with PIs, NRTIs, and NNRTI-resistant variants.
- Treatment-experienced HIV-infected pediatric patients (6 -18 years of age and weighing at least 16 kg).
- Potential for use in first-line therapy for pts infected with NNRTI-resistant virus (untested)
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
- In combination with other ARV agents for the treatment of HIV-1 infection in treatment-experienced pts with PIs, NRTIs, and NNRTI-resistant variants.
- Treatment-experienced HIV-infected pediatric patients (6 -18 years of age and weighing at least 16 kg).
- Potential for use in first-line therapy for pts infected with NNRTI-resistant virus (untested)
There's more to see -- the rest of this entry is available only to subscribers.
© 2000–2022 Unbound Medicine, Inc. All rights reserved